Tharimmune, Inc. (THAR) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is neutral — 1 Hold.
Analysts estimate Earnings Per Share (EPS) of $-7.93 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-9.41 vs est $-7.93 (missed -18.7%). 2025: actual $-1.12 vs est $-7.06 (beat +84.1%). Analyst accuracy: 0%.
THAR Analyst Ratings
Hold
Based on 1 analysts giving stock ratings to Tharimmune, Inc. in the past 3 months
EPS Estimates — THAR
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$9.41
vs Est –$7.93
▼ 15.8% off
2025
Actual –$1.12
vs Est –$7.06
▲ 530.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — THAR
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
